Search results
Syncona merges Freeline and SwanBio to spur new gene-therapy-focused biotech
FierceBiotech· 7 days agoSeven months after Syncona threw a financial lifeline to struggling Freeline Therapeutics, the...
Ride supports cell therapy at Roswell
WGRZ-TV Buffalo· 2 days agoChris Vogelsang says he takes plenty of time to reflect these days. On this night one year ago, he served as a flag bearer during Roswell Park’s...
New Guidance on CGRPs: How/Will it Shape Clinical Practice?
Medscape· 4 days ago/Will it Change Clinical Practice? A position statement released by the American Headache Society...
How to recover from burnout in six steps
The Telegraph via Yahoo News· 9 hours agoBurnout is a buzzword which is often bandied about when we feel a bit tired at work and overwhelmed by life. In fact, it is a syndrome with clear...
Eli Lilly seeks FDA’s OK to expand Zepbound’s uses to include sleep apnea
Market Watch· 2 days agoFor more than half of patients who use the common sleep-apnea therapy PAP, or positive airway...
USA Swimming therapy dog retires, named honorary member of the team
Washington Post· 4 days ago“That’s what athletes are looking for … In high energy environments like this, we have to have environments where they can get away from the hype, they can calm their nervous systems down.”
This little-known biotech stock is primed to surge nearly 50%, Canaccord says
CNBC· 3 days agoPositive data from Intra-Cellular Therapies ' latest study could herald further success for the...
Mama June Praises Husband Justin for Helping Her Family amid Hardships: 'Appreciate Him Even More'...
People via Yahoo News· 3 days agoMama June/Instagram Mama June with her family June now confirms to PEOPLE that they still "have not"...
Sarepta surges as investors cheer expanded use of gene therapy
WSAU Wausau· 3 days ago(Reuters) - Sarepta Therapeutics shares surged about 36% in premarket trading on Friday as an expanded use approval opened up a bigger market in the U.S. for its gene therapy
FDA lifts hold on PTC Huntington’s disease trial
BioPharma Dive via Yahoo Finance· 4 days agoThat compares with a 1-point improvement for people who got the UniQure gene therapy, analysts wrote. However, PTC518 didn’t appear to have any impact on...
